Reuters logo
BRIEF-U.S. FDA approves kaléo's AUVI-Q 0.1 mg auto-injector for life-threatening allergic reactions in infants and small children
November 20, 2017 / 1:49 PM / 21 days ago

BRIEF-U.S. FDA approves kaléo's AUVI-Q 0.1 mg auto-injector for life-threatening allergic reactions in infants and small children

Nov 20 (Reuters) - ‍kaléo

* U.S. FDA approves kaléo’s AUVI-Q® (Epinephrine injection, USP) 0.1 mg auto-injector for life-threatening allergic reactions in infants and small children

* ‍kaléo - AUVI-Q 0.1 mg auto-injector is projected to be available for patients in first half of 2018​ Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below